A headspace GC–MS method to quantify nitrosamine impurities and precursors in drug products: Method validation and product testing
Biomedical Chromatography · 2025-01 · 39 (1)
DOI: 10.1002/bmc.6040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 07.11.2024. Verfasst von Susan Daniela Selaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Office of Pharmaceutical Quality Research, Center for Drug Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Drug Contamination, Nitrosamines, Gas Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: U.S. Food and Drug Administration, Oak Ridge Institute for Science and Education, U.S. Department of Energy (Office of Science, Office of Basic Energy Sciences and Energy Efficiency and Renewable Energy, Solar Energy Technology Program).
Abstract (Originalsprache)
Pharmaceutical manufacturers are working to mitigate the formation of nitrosamine impurities in drug products. The work herein describes the development and validation of a headspace GC–MS method according to ICH Q2(R1) guidelines for the detection and quantification of NDMA, NDEA, NDIPA, and NEIPA in drug products. The analytical procedure was further modified to include detection and quantitation of DMF due to the potential decomposition pathway of DMF to form dimethylamine, a known precursor for NDMA formation. The NDMA impurity was detected in the “sartan” class of drug products between 0.1 and 113 ppm. The validated analytical procedure was applied in an investigation of approaches to mitigate nitrosamine formation in metformin drug products. The developed analytical procedures provide another tool for pharmaceutical manufacturers to evaluate drug products for nitrosamine impurities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Office of Pharmaceutical Quality Research, Center for Drug Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, USA.
- Office of Product Quality Assessment, Center for Drug Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, USA.
- Office of Regulatory Science, Center for Food Safety and Applied Nutrition, College Park, Maryland, USA.
ORCID-Profile: Patrick Faustino, Diaa Shakleya
Förderung
- U.S. Food and Drug Administration
- Oak Ridge Institute for Science and Education
- U.S. Department of Energy (Office of Science, Office of Basic Energy Sciences and Energy Efficiency and Renewable Energy, Solar Energy Technology Program)
Zitieren
APA
Selaya, S. D., Abrigo, N., Brown, D. G., Desai, S., Beekman, C., Faustino, P., & Shakleya, D. (2025). A headspace GC–MS method to quantify nitrosamine impurities and precursors in drug products: Method validation and product testing. Biomedical Chromatography, 39(1). https://doi.org/10.1002/bmc.6040
Vancouver
Selaya SD, Abrigo N, Brown DG, Desai S, Beekman C, Faustino P, et al. A headspace GC–MS method to quantify nitrosamine impurities and precursors in drug products: Method validation and product testing. Biomedical Chromatography. 2025;39(1). doi:10.1002/bmc.6040
BibTeX
@article{Selaya2025,
author = {Selaya, Susan Daniela and Abrigo, Nicolas and Brown, Dustin G and Desai, Saaniya and Beekman, Christopher and Faustino, Patrick and Shakleya, Diaa},
title = {A headspace GC–MS method to quantify nitrosamine impurities and precursors in drug products: Method validation and product testing},
journal = {Biomedical Chromatography},
year = {2025},
volume = {39},
number = {1},
doi = {10.1002/bmc.6040}
}
EUVIMED